Download PDF
Suchttherapie 2019; 20(03): 129-134
DOI: 10.1055/a-0947-2975
Schwerpunktthema
© Georg Thieme Verlag KG Stuttgart · New York

Suizidalität bei Abhängigkeit von illegalen Substanzen und psychotrop wirksamen Medikamenten

Suicidality in Dependence on Illegal Substances and Psychotropic Drugs
Barbara Schneider
1   Abteilung für Abhängigkeitserkrankungen, Psychiatrie und Psychotherapie, LVR-Klinik Köln
2   Klinik für Psychiatrie, Psychosomatik und Psychotherapie, Universitätsklinikum Frankfurt am Main
,
Lisa Eilert
1   Abteilung für Abhängigkeitserkrankungen, Psychiatrie und Psychotherapie, LVR-Klinik Köln
,
Sascha Milin
3   Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf (UKE)
4   Zentrum für Interdisziplinäre Suchtforschung (ZIS) der Universität Hamburg
,
Ingo Schäfer
3   Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf (UKE)
4   Zentrum für Interdisziplinäre Suchtforschung (ZIS) der Universität Hamburg
› Author Affiliations
Further Information

Publication History

Publication Date:
07 August 2019 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Psychische Erkrankungen sind die wichtigsten einzelnen Risikofaktoren für Suizid, wobei Abhängigkeitserkrankungen eine bedeutende Rolle spielen. In diese Übersicht wurden Kohortenstudien und kontrollierte psychologische Autopsiestudien sowie Reviews, die bis 2019 publiziert wurden, zum Risiko für suizidales Verhalten einschließlich Suizid, bei Abhängigkeit von psychotrop wirksamen Medikamenten (Opioiden und Benzodiazepinen) und Konsum von illegalen Substanzen eingeschlossen. Bei allen untersuchten substanzbezogenen Störungen, insbesondere bei Konsum von Opioiden und Mischkonsum, war das Suizidrisiko stark erhöht. So ist beispielsweise bei Drogenabhängigkeit das Suizidrisiko etwa um das 20-Fache gegenüber der Allgemeinbevölkerung erhöht.

Zusammenhänge zwischen Konsum von Drogen und Medikamenten und Entstehung von Suizidalität sind sehr komplex, was sich letztlich auch auf Möglichkeiten der Suizidprävention bei Suchterkrankungen auswirkt.

Abstract

Mental illness is the most important single risk factor for suicide, with dependence disorders playing an important role. This review included cohort studies and controlled psychological autopsy studies and reviews published up to 2019 on the risk of suicidal behaviour including suicide, dependence on psychotropic drugs (opioids and benzodiazepines) and use of illicit substances. The risk of suicide was highly increased in all substance-related disorders studied, especially in opioid and mixed use. For example, the risk of suicide in drug addicts is about 20 times higher than that in the general population.

The relationship between the consumption of drugs and psychotropic medication and the development of suicidal tendencies is very complex, which ultimately also has an effect on the opportunities of suicide prevention in addiction disorders.

Schlüsselwörter

Suizidalität - illegale Substanzen - Medikamente

Key words

suicidality - illegal substances - psychotropic drugs
 

  • Literatur

  • 1 World Health Organization. Suicide prevention: A global imperative. In: http://www who int/mental_health/suicide-prevention/world_report_2014/en/
    PubMed
  • 2 Wilcox HC, Conner KR, Caine ED. Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies. Drug and Alcohol Dependence 2004; 76 Suppl S11-S19 doi: 10.1016/j.drugalcdep.2004.08.003
    CrossrefPubMedGoogle Scholar
  • 3 Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997; 170: 205-228
    CrossrefPubMedGoogle Scholar
  • 4 Cavanagh JT, Carson AJ, Sharpe M. et al. Psychological autopsy studies of suicide: a systematic review. Psychol Med 2003; 33: 395-405
    CrossrefPubMedGoogle Scholar
  • 5 Arsenault-Lapierre G, Kim C, Turecki G. Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry 2004; 4: 37. doi: 1471-244X-4-37
    CrossrefPubMedGoogle Scholar
  • 6 Schneider B. Substance use disorders and risk for completed suicide. Arch Suicide Res 2009; 13: 303-316 doi: 10.1080/13811110903263191
    CrossrefPubMedGoogle Scholar
  • 7 Weltgesundheitsorganisation. Global health risks: Mortality and burden of disease attributable to selected major risks. Genf: World Health Organisation; 2014
    Google Scholar
  • 8 Statistisches Bundesamt Deutschland. Sterbefälle nach äußeren Ursachen und ihren Folgen (ab 1998) In 2019; http://www.gbe-bund.de/oowa921-install/servlet/oowa/aw92/dboowasys921.xwdevkit/xwd_init?gbe.isgbetol/xs_start_neu/&p_aid=i&p_aid=72980652&nummer=6&p_sprache=D&p_indsp=-&p_aid=87470402
    PubMed
  • 9 Schmidtke A, Bille-Brahe U, DeLeo D. et al. Suicidal Behaviour in Europe: Results from the WHO/Euro Multicentre Study on Suicidal Behaviour. Göttingen: Hogrefe; 2002
    Google Scholar
  • 10 Shneidman ES. Forward In: Cain AC. (Hrsg.) Survivors of suicide. Springfield, IL: CC Thomas; 1972: ix-xi
    Google Scholar
  • 11 Berman AL. Estimating the population of survivors of suicide: seeking an evidence base. Suicide Life Threat Behav 2011; 41: 110-116 doi: 10.1111/j.1943-278X.2010.00009.x
    CrossrefPubMedGoogle Scholar
  • 12 UNODC United Nations Office on Drugs and Crime. Word Drug Report 2018. Wien: United Nations publication; 2018
    Google Scholar
  • 13 Gomes de Mateo E, Atzendorf J, Kraus L. et al. Substanzkonsum in der Allgemeinbevölkerung in Deutschland. Ergebnisse des Epidemiologischen Suchtsurveys 2015. Sucht 2016; 62: 271-281 doi: 10.1024/0939-5911/a000445
    CrossrefPubMedGoogle Scholar
  • 14 Kraus L, Atzendorf J, Schiele C. et al. Substanzbezogene Störungen. Ein gesellschaftliches Problem. Kerbe – Forum für soziale Psychiatrie 2019; 37: 9-12
    PubMedGoogle Scholar
  • 15 Backmund M, Schutz CG, Meyer K. et al. Alcohol consumption in heroin users, methadone-substituted and codeine-substituted patients--frequency and correlates of use. Eur Addict Res 2003; 9: 45-50 doi: 10.1159/000067733
    CrossrefPubMedGoogle Scholar
  • 16 Wetterling T, Kugler C. Ältere Suchtkranke im psychiatrischen Krankenhaus. Z Gerontopsychol Psychiat 2006; 19: 195-200
    PubMedGoogle Scholar
  • 17 CDC Center for Disease Control and Prevention. 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes – United States. Atlanta, Georgia: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2018
    Google Scholar
  • 18 Schneider B, Wetterling T. Sucht und Suizidalität. Stuttgart: Kohlhammer; 2015
    Google Scholar
  • 19 Schneider B. Risikofaktoren für Suizid. Regensburg: Roderer; 2003
    Google Scholar
  • 20 Nordentoft M, Mortensen PB, Pedersen CB. Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry 2011; 68: 1058-1064. doi:10.1001/archgenpsychiatry.2011.113
    CrossrefPubMedGoogle Scholar
  • 21 Pirkola SP, Isometsä ET, Heikkinen ME. et al. Female psychoactive substance-dependent suicide victims differ from male – results from a nationwide psychological autopsy study. Compr Psychiatry 1999; 40: 101-107 doi: S0010-440X(99)90113-X
    CrossrefPubMedGoogle Scholar
  • 22 Pirkola S. Alcohol and other substance misuse in suicide. Academic dissertation 1999
    PubMed
  • 23 Lee CT, Chen VC, Tan HK. et al. Suicide and other-cause mortality among heroin users in Taiwan: a prospective study. Addict Behav 2013; 38: 2619-2623. doi:10.1016/j.addbeh.2013.03.003
    CrossrefPubMedGoogle Scholar
  • 24 Darke S, Ross J. Suicide among heroin users: rates, risk factors and methods. Addiction 2002; 97: 1383-1394
    CrossrefPubMedGoogle Scholar
  • 25 Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997; 170: 205-228
    CrossrefPubMedGoogle Scholar
  • 26 Petit A, Reynaud M, Lejoyeux M. et al. Addiction à la cocaïne: un facteur de risque de suicide [Addiction to cocaine: a risk factor for suicide?]. Presse Med 2012; 41: 702-712. doi:10.1016/j.lpm.2011.12.006
    CrossrefPubMedGoogle Scholar
  • 27 Kittirattanapaiboon P, Suttajit S, Junsirimongkol B. et al. Suicide risk among Thai illicit drug users with and without mental/alcohol use disorders. Neuropsychiatr Dis Treat 2014; 10: 453-458 doi:10.2147/NDT.S56441
    PubMedGoogle Scholar
  • 28 Arendt M, Munk-Jorgensen P, Sher L. et al. Mortality following treatment for cannabis use disorders: predictors and causes. J Subst Abuse Treat 2013; 44: 400-406 doi:10.1016/j.jsat.2012.09.007
    CrossrefPubMedGoogle Scholar
  • 29 Andreasson S, Allebeck P. Cannabis and mortality among young men: A longitudinal study of Swedish conscripts. Scand J Soc Med 1990; 18: 9-15
    PubMedGoogle Scholar
  • 30 Price C, Hemmingsson T, Lewis G. et al. Cannabis and suicide: longitudinal study. Br J Psychiatry 2009; 195: 492-497 doi:10.1192/bjp.bp.109.065227
    CrossrefPubMedGoogle Scholar
  • 31 Bernard JP, Havnes I, Slordal L. et al. Methadone-related deaths in Norway. Forensic Sci Int 2013; 224: 111-116 doi:10.1016/j.forsciint.2012.11.010
    CrossrefPubMedGoogle Scholar
  • 32 Voaklander DC, Rowe BH, Dryden DM. et al. Medical illness, medication use and suicide in seniors: a population-based case-control study. J Epidemiol Community Health 2008; 62: 138-146. doi:10.1136/jech.2006.055533
    CrossrefPubMedGoogle Scholar
  • 33 Cheng AT. Mental illness and suicide. A case-control study in east Taiwan. Arch Gen Psychiatry 1995; 52: 594-603
    CrossrefPubMedGoogle Scholar
  • 34 Isometsä ET, Henriksson MM, Heikkinen ME. et al. Suicide among subjects with personality disorders. Am J Psychiatry 1996; 153: 667-673
    CrossrefPubMedGoogle Scholar
  • 35 Conwell Y, Duberstein PR, Cox C. et al. Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. Am J Psychiatry 1996; 153: 1001-1008
    CrossrefPubMedGoogle Scholar
  • 36 Cheng AT, Mann AH, Chan KA. Personality disorder and suicide. A case-control study. Br J Psychiatry 1997; 170: 441-446
    CrossrefPubMedGoogle Scholar
  • 37 Brent DA, Perper JA, Moritz G. et al. Psychiatric risk factors for adolescent suicide: a case-control study. J Am Acad Child Adolesc Psychiatry 1993; 32: 521-529 doi:10.1097/00004583-199305000-00006
    CrossrefPubMedGoogle Scholar
  • 38 Wines Jr. JD, Saitz R, Horton NJ. et al. Suicidal behavior, drug use and depressive symptoms after detoxification: a 2-year prospective study. Drug Alcohol Depend 2004; 76 Suppl S21-S29 doi:10.1016/j.drugalcdep.2004.08.004
    CrossrefPubMedGoogle Scholar
  • 39 Wang LJ, Chiang SC, Su LW. et al. Factors associated with drug-related psychiatric disorders and suicide attempts among illicit drug users in Taiwan. Subst Use Misuse 2012; 47: 1185-1188 doi:10.3109/10826084.2012.690812
    CrossrefPubMedGoogle Scholar
  • 40 Maloney E, Degenhardt L, Darke S. et al. Suicidal behaviour and associated risk factors among opioid-dependent individuals: a case-control study. Addiction 2007; 102: 1933-1941 doi: 10.1111/j.1360-0443.2007.01971.x
    CrossrefPubMedGoogle Scholar
  • 41 Wong SS, Zhou B, Goebert D. et al. The risk of adolescent suicide across patterns of drug use: a nationally representative study of high school students in the United States from 1999 to 2009. Soc Psychiatry Psychiatr Epidemiol 2013; 48: 1611-1620 doi: 10.1007/s00127-013-0721-z
    CrossrefPubMedGoogle Scholar
  • 42 Darke S, Ross J, Marel C. et al. Patterns and correlates of attempted suicide amongst heroin users: 11-year follow-up of the Australian treatment outcome study cohort. Psychiatry Res 2015; 227: 166-170 doi: 10.1016/j.psychres.2015.04.010
    CrossrefPubMedGoogle Scholar
  • 43 Trémeau F, Darreye A, Staner L. et al. Suicidality in opioid-dependent subjects. Am J Addict 2008; 17: 187-194. doi: 10.1080/10550490802020160
    CrossrefPubMedGoogle Scholar
  • 44 Maloney E, Degenhardt L, Darke S. et al. Impulsivity and borderline personality as risk factors for suicide attempts among opioid-dependent individuals. Psychiatry Res 2009; 169: 16-21 doi:10.1016/j.psychres.2008.06.026
    CrossrefPubMedGoogle Scholar
  • 45 Noori R, Rafiey H, Azizabadi-Farahani M. et al. Risk factors of suicidal ideation and attempt in women with drug user spouses. J Chin Med Assoc 2013; 76: 648-652. doi: 10.1016/j.jcma.2013.07.003
    CrossrefPubMedGoogle Scholar
  • 46 Ashrafioun L, Bishop TM, Conner KR. et al. Frequency of prescription opioid misuse and suicidal ideation, planning, and attempts. J Psychiatr Res 2017; 92: 1-7. doi: 10.1016/j.jpsychires.2017.03.011
    CrossrefPubMedGoogle Scholar
  • 47 Baiden P, Graaf G, Zaami M. et al. Examining the association between prescription opioid misuse and suicidal behaviors among adolescent high school students in the United States. J Psychiatr Res 2019; 112: 44-51 doi: 10.1016/j.jpsychires.2019.02.018
    CrossrefPubMedGoogle Scholar
  • 48 Pedersen W. Does cannabis use lead to depression and suicidal behaviours? A population-based longitudinal study. Acta Psychiatr Scand 2008; 118: 395-403. doi: 10.1111/j.1600-0447.2008.01259.x
    CrossrefPubMedGoogle Scholar
  • 49 Rasic D, Weerasinghe S, Asbridge M. et al. Longitudinal associations of cannabis and illicit drug use with depression, suicidal ideation and suicidal attempts among Nova Scotia high school students. Drug Alcohol Depend 2013; 129: 49-53 doi: 10.1016/j.drugalcdep.2012.09.009
    CrossrefPubMedGoogle Scholar
  • 50 Borges G, Benjet C, Orozco R. et al. Alcohol, cannabis and other drugs and subsequent suicide ideation and attempt among young Mexicans. J Psychiatr Res 2017; 91: 74-82. doi: 10.1016/j.jpsychires.2017.02.025
    CrossrefPubMedGoogle Scholar
  • 51 Choi NG, DiNitto DM, Marti CN. et al. Relationship between marijuana and other illicit drug use and depression/suicidal thoughts among late middle-aged and older adults. Int Psychogeriatr 2016; 28: 577-589. doi: 10.1017/S1041610215001738
    CrossrefPubMedGoogle Scholar
  • 52 Glasner-Edwards S, Mooney LJ, Marinelli-Casey P. et al. Risk factors for suicide attempts in methamphetamine-dependent patients. Am J Addict 2008; 17: 24-27. doi: 10.1080/10550490701756070
    CrossrefPubMedGoogle Scholar
  • 53 Marshall BD, Galea S, Wood E. et al. Injection methamphetamine use is associated with an increased risk of attempted suicide: a prospective cohort study. Drug Alcohol Depend 2011; 119: 134-137 doi: 10.1016/j.drugalcdep.2011.05.012
    CrossrefPubMedGoogle Scholar
  • 54 Schepis TS, McCabe SE. Prescription Tranquilizer/Sedative Sources for Misuse in Older Adults. Subst Use Misuse 2019; DOI: 10.1080/10826084.2019.1613434.
    CrossrefPubMedGoogle Scholar
  • 55 Wetterling T, Schneider B. Medikamentenmissbrauch bei älteren psychiatrischen Patienten [Prescription drug abuse in elderly psychiatric patients]. Psychiatr Prax 2012; 39: 275-279 doi: 10.1055/s-0032-1305043
    Article in Thieme ConnectPubMedGoogle Scholar
  • 56 Hilts KE, Greene M. Mental Health, Substance Misuse, and Suicide: Shared Risk and Protective Factors. Indianapolis, IN: The Center for Health Policy at the IU Richard M. Fairbanks School of Public Health; 2018. DOI: http://hdl.handle.net/1805/16542
    CrossrefGoogle Scholar
  • 57 Hufford MR. Alcohol and suicidal behavior. Clin Psychol Rev 2001; 21: 797-811 doi:S0272-7358(00)00070-2 [pii]
    CrossrefPubMedGoogle Scholar
  • 58 Carretta CM, Burgess AW, Dowdell EB. et al. Adolescent suicide cases: Toxicology reports and prescription drugs. J Nurse Practitioners 2018; 14: 552-558
    PubMedGoogle Scholar